.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Future Leaders in Neurology
NMOSD Disease Spotlight
AHS 2022
ATMRD 2022
SLEEP 2022

Clinical FocusSee All >

Dementia/Alzheimer
Epilepsy
Headache/Migraine
Movement Disorders
Multiple Sclerosis
Neuromuscular
Sleep Medicine
Stroke

Video Series

Cure Connections
Insights
NeurologyLive Peer Exchange
News Network

About Us
Advisory Board
Editorial
Contact Us
Advertise
Contact MJH LS
Do Not Sell My Information
Terms and Conditions
Privacy

Advances in Early Treatment Approaches in Multiple Sclerosis

EP. 1: Updated McDonald Criteria for Diagnosing MS

February 14th 2020

EP. 2: Diagnostic Work-Up for MS

February 14th 2020

EP. 3: MRI in the Diagnosis of MS

February 14th 2020

EP. 4: Clinical Courses in MS

February 14th 2020

EP. 5: Modern Conversion Rate to Secondary MS

February 14th 2020

EP. 6: Importance of Early Treatment of MS

February 14th 2020

EP. 7: Choosing Initial Therapy for Treatment of MS

February 14th 2020

EP. 8: Factors to Consider for First-Line Therapy for MS

February 14th 2020

EP. 9: Recent Treatment Strategies Explored for Relapsing MS

February 14th 2020

EP. 10: ASSESS Clinical Trial of Fingolimod for Treatment of MS

February 14th 2020

Latest News

NeurologyLive® Top Expert Interviews: June 2022

Utilizing the Mayo Clinic 3-M Approach for Different Autoimmune Disorder Presentations: Sean Pittock, MD

FDA Accepts BLA for Lecanemab in Alzheimer Disease, Sets PDUFA Date for January 2023

Cure CMD: Benefits of the Annual SciFam Conference

View More News